Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 U.S. heparin industry 360 degree synopsis, 2015-2026
2.1.1 Business trends
Chapter 3 US Heparin Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2015 - 2026
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of chronic diseases
3.3.1.2 High demand for anti-coagulant products
3.3.1.3 Rising geriatric population in U.S.
3.3.2 Industry pitfalls & challenges
3.3.2.1 High risk of side effects
3.3.2.2 High dependency on porcine
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By distribution channel
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2019
3.7.1 Company share analysis, 2019
3.7.2 Company matrix analysis
3.8 PESTEL analysis
Chapter 4 US Heparin Market, By Product
4.1 Key segment trends
4.2 Low molecular weight heparin
4.2.1 Market size, 2015 - 2026 (USD Million)
4.3 Unfractionated heparin
4.3.1 Market size, 2015 - 2026 (USD Million)
Chapter 5 US Heparin Market, By Application
5.1 Key segment trends
5.2 Venous thromboembolism
5.2.1 Market size, 2015 - 2026 (USD Million)
5.3 Atrial fibrillation/flutter
5.3.1 Market size, 2015 - 2026 (USD Million)
5.4 Coronary artery disease
5.4.1 Market size, 2015 - 2026 (USD Million)
5.5 Others
5.5.1 Market size, 2015 - 2026 (USD Million)
Chapter 6 US Heparin Market, By Distribution Channel
6.1 Key segment trends
6.2 Hospital pharmacy
6.2.1 Market size, 2015 - 2026 (USD Million)
6.3 Retail pharmacy
6.3.1 Market size, 2015 - 2026 (USD Million)
6.4 Online pharmacy
6.4.1 Market size, 2015 - 2026 (USD Million)
Chapter 7 Company Profiles
7.1 Competitive dashboard, 2019
7.2 Amphastar Pharmaceutical
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Changzhou Qianhong Biopharma Co , Ltd
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Fresenius Kabi
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 Leo Pharma A/S
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Nanjing King-Friend Biochemical Pharmaceutical
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Pfizer, Inc
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Sanofi
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Shenzhen Hepalink
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 Yantai Dongcheng Biochemical Co , Ltd
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis



List of Tables

Data Tables
TABLE 1 U.S. heparin market size, 2015 - 2026 (USD Million)
TABLE 2 U.S. heparin market size, 2015 - 2019 (USD Million)
TABLE 3 Industry impact forces
TABLE 4 U.S. low molecular weight heparin market size, 2015 - 2019 (USD Million)
TABLE 5 U.S. low molecular weight heparin market size, 2020 - 2026 (USD Million)
TABLE 6 U.S. unfractionated heparin market size, 2015 - 2019 (USD Million)
TABLE 7 U.S. unfractionated heparin market size, 2020 - 2026 (USD Million)
TABLE 8 U.S. venous thromboembolism market size, 2015 - 2019 (USD Million)
TABLE 9 U.S. venous thromboembolism market size, 2020 - 2026 (USD Million)
TABLE 10 U.S. atrial fibrillation/flutter market size, 2015 - 2019 (USD Million)
TABLE 11 U.S. atrial fibrillation/flutter market size, 2020 - 2026 (USD Million)
TABLE 12 U.S. coronary heart disease market size, 2015 - 2019 (USD Million)
TABLE 13 U.S. coronary heart disease market size, 2020 - 2026 (USD Million)
TABLE 14 Others market size, 2015 - 2019 (USD Million)
TABLE 15 Others market size, 2020 - 2026 (USD Million)
TABLE 16 U.S. hospital pharmacy market size, 2015 - 2019 (USD Million)
TABLE 17 U.S. hospital pharmacy market size, 2020 - 2026 (USD Million)
TABLE 18 U.S. retail pharmacy market size, 2015 - 2019 (USD Million)
TABLE 19 U.S. retail pharmacy market size, 2020 - 2026 (USD Million)
TABLE 20 U.S. online pharmacy market size, 2015 - 2019 (USD Million)
TABLE 21 U.S. online pharmacy market size, 2020 - 2026 (USD Million)

Charts & Figures
FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 U.S. heparin industry 360 degree synopsis
FIG. 4 Industry segmentation
FIG. 5 U.S. heparin market, 2015 - 2026 (USD Million)
FIG. 6 Growth potential analysis, by product
FIG. 7 Growth potential analysis, by application
FIG. 8 Growth potential analysis, by distribution channel
FIG. 9 Porter’s analysis
FIG. 10 U.S. company share analysis, 2019
FIG. 11 Company matrix analysis, 2019
FIG. 12 PESTEL analysis
FIG. 13 Key segment trends, by product
FIG. 14 Key segment trends, by application
FIG. 15 Key segment trends, by distribution channel
FIG. 16 Competitive dashboard, 2019